(2R,3S)-2-[4-(cyclobutylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-2-[4-(cyclopentylamino)phenyl]-N-[4-ethyl-3-(trifluoromethyl)phenyl]-1-(2-fluoro-6-methylbenzoyl)-6-methyl-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-[(2-hydroxy-2-methylpropyl)amino]phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-(propan-2-ylamino)phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide

C146H149F7N12O12 — CID 158898922

IUPAC(2R,3S)-2-[4-(cyclobutylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-2-[4-(cyclopentylamino)phenyl]-N-[4-ethyl-3-(trifluoromethyl)phenyl]-1-(2-fluoro-6-methylbenzoyl)-6-methyl-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-[(2-hydroxy-2-methylpropyl)amino]phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-(propan-2-ylamino)phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide
SMILESCCc1ccc(NC(=O)[C@H]2Cc3cc(C)ccc3N(C(=O)c3c(C)cccc3F)[C@H]2c2ccc(NC3CCCC3)cc2)cc1C(F)(F)F.Cc1cc(NC(=O)[C@H]2Cc3ccccc3N(C(=O)c3c(C)cccc3F)[C@H]2c2ccc(NC(C)C)cc2)ccc1CO.Cc1cc(NC(=O)[C@H]2Cc3ccccc3N(C(=O)c3c(C)cccc3F)[C@H]2c2ccc(NC3CCC3)cc2)ccc1CO.Cc1cc(NC(=O)[C@H]2Cc3ccccc3N(C(=O)c3c(C)cccc3F)[C@H]2c2ccc(NCC(C)(C)O)cc2)ccc1CO
InChIInChI=1S/C39H39F4N3O2.C36H38FN3O4.C36H36FN3O3.C35H36FN3O3/c1-4-25-13-18-30(22-32(25)39(41,42)43)45-37(47)31-21-27-20-23(2)12-19-34(27)46(38(48)35-24(3)8-7-11-33(35)40)36(31)26-14-16-29(17-15-26)44-28-9-5-6-10-28;1-22-8-7-10-30(37)32(22)35(43)40-31-11-6-5-9-25(31)19-29(34(42)39-28-17-14-26(20-41)23(2)18-28)33(40)24-12-15-27(16-13-24)38-21-36(3,4)44;1-22-7-5-11-31(37)33(22)36(43)40-32-12-4-3-8-25(32)20-30(35(42)39-29-18-15-26(21-41)23(2)19-29)34(40)24-13-16-28(17-14-24)38-27-9-6-10-27;1-21(2)37-27-15-12-24(13-16-27)33-29(34(41)38-28-17-14-26(20-40)23(4)18-28)19-25-9-5-6-11-31(25)39(33)35(42)32-22(3)8-7-10-30(32)36/h7-8,11-20,22,28,31,36,44H,4-6,9-10,21H2,1-3H3,(H,45,47);5-18,29,33,38,41,44H,19-21H2,1-4H3,(H,39,42);3-5,7-8,11-19,27,30,34,38,41H,6,9-10,20-21H2,1-2H3,(H,39,42);5-18,21,29,33,37,40H,19-20H2,1-4H3,(H,38,41)/t31-,36-;29-,33-;30-,34-;29-,33-/m0000/s1
InChIKeyJFEJJRDCPVKOFT-ZKDQBUHZSA-N
MW2396.86 g/mol
LogP29.95
Rot. Bonds29

About (2R,3S)-2-[4-(cyclobutylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-2-[4-(cyclopentylamino)phenyl]-N-[4-ethyl-3-(trifluoromethyl)phenyl]-1-(2-fluoro-6-methylbenzoyl)-6-methyl-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-[(2-hydroxy-2-methylpropyl)amino]phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-(propan-2-ylamino)phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide

(2R,3S)-2-[4-(cyclobutylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-2-[4-(cyclopentylamino)phenyl]-N-[4-ethyl-3-(trifluoromethyl)phenyl]-1-(2-fluoro-6-methylbenzoyl)-6-methyl-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-[(2-hydroxy-2-methylpropyl)amino]phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-(propan-2-ylamino)phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide (PubChem CID 158898922) has the molecular formula C146H149F7N12O12 and a molecular weight of 2396.86 g/mol. Its IUPAC name is (2R,3S)-2-[4-(cyclobutylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-2-[4-(cyclopentylamino)phenyl]-N-[4-ethyl-3-(trifluoromethyl)phenyl]-1-(2-fluoro-6-methylbenzoyl)-6-methyl-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-[(2-hydroxy-2-methylpropyl)amino]phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-(propan-2-ylamino)phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide.

Molecular Properties

Compound Name(2R,3S)-2-[4-(cyclobutylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-2-[4-(cyclopentylamino)phenyl]-N-[4-ethyl-3-(trifluoromethyl)phenyl]-1-(2-fluoro-6-methylbenzoyl)-6-methyl-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-[(2-hydroxy-2-methylpropyl)amino]phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-(propan-2-ylamino)phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide
PubChem CID158898922
Molecular FormulaC146H149F7N12O12
Molecular Weight2396.86 g/mol
Exact Mass2395.13
IUPAC Name(2R,3S)-2-[4-(cyclobutylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-2-[4-(cyclopentylamino)phenyl]-N-[4-ethyl-3-(trifluoromethyl)phenyl]-1-(2-fluoro-6-methylbenzoyl)-6-methyl-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-[(2-hydroxy-2-methylpropyl)amino]phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-(propan-2-ylamino)phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide
SMILESCCc1ccc(NC(=O)[C@H]2Cc3cc(C)ccc3N(C(=O)c3c(C)cccc3F)[C@H]2c2ccc(NC3CCCC3)cc2)cc1C(F)(F)F.Cc1cc(NC(=O)[C@H]2Cc3ccccc3N(C(=O)c3c(C)cccc3F)[C@H]2c2ccc(NC(C)C)cc2)ccc1CO.Cc1cc(NC(=O)[C@H]2Cc3ccccc3N(C(=O)c3c(C)cccc3F)[C@H]2c2ccc(NC3CCC3)cc2)ccc1CO.Cc1cc(NC(=O)[C@H]2Cc3ccccc3N(C(=O)c3c(C)cccc3F)[C@H]2c2ccc(NCC(C)(C)O)cc2)ccc1CO
InChIInChI=1S/C39H39F4N3O2.C36H38FN3O4.C36H36FN3O3.C35H36FN3O3/c1-4-25-13-18-30(22-32(25)39(41,42)43)45-37(47)31-21-27-20-23(2)12-19-34(27)46(38(48)35-24(3)8-7-11-33(35)40)36(31)26-14-16-29(17-15-26)44-28-9-5-6-10-28;1-22-8-7-10-30(37)32(22)35(43)40-31-11-6-5-9-25(31)19-29(34(42)39-28-17-14-26(20-41)23(2)18-28)33(40)24-12-15-27(16-13-24)38-21-36(3,4)44;1-22-7-5-11-31(37)33(22)36(43)40-32-12-4-3-8-25(32)20-30(35(42)39-29-18-15-26(21-41)23(2)19-29)34(40)24-13-16-28(17-14-24)38-27-9-6-10-27;1-21(2)37-27-15-12-24(13-16-27)33-29(34(41)38-28-17-14-26(20-40)23(4)18-28)19-25-9-5-6-11-31(25)39(33)35(42)32-22(3)8-7-10-30(32)36/h7-8,11-20,22,28,31,36,44H,4-6,9-10,21H2,1-3H3,(H,45,47);5-18,29,33,38,41,44H,19-21H2,1-4H3,(H,39,42);3-5,7-8,11-19,27,30,34,38,41H,6,9-10,20-21H2,1-2H3,(H,39,42);5-18,21,29,33,37,40H,19-20H2,1-4H3,(H,38,41)/t31-,36-;29-,33-;30-,34-;29-,33-/m0000/s1
InChIKeyJFEJJRDCPVKOFT-ZKDQBUHZSA-N
XLogP29.95
TPSA326.68 Ų
H-Bond Donors12
H-Bond Acceptors16
Rotatable Bonds29
Heavy Atoms177
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002396.86
LogP ≤ 529.95
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1016

Analyze (2R,3S)-2-[4-(cyclobutylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-2-[4-(cyclopentylamino)phenyl]-N-[4-ethyl-3-(trifluoromethyl)phenyl]-1-(2-fluoro-6-methylbenzoyl)-6-methyl-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-[(2-hydroxy-2-methylpropyl)amino]phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-(propan-2-ylamino)phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R,3S)-2-[4-(cyclobutylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-2-[4-(cyclopentylamino)phenyl]-N-[4-ethyl-3-(trifluoromethyl)phenyl]-1-(2-fluoro-6-methylbenzoyl)-6-methyl-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-[(2-hydroxy-2-methylpropyl)amino]phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-(propan-2-ylamino)phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide?
The IUPAC name of (2R,3S)-2-[4-(cyclobutylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-2-[4-(cyclopentylamino)phenyl]-N-[4-ethyl-3-(trifluoromethyl)phenyl]-1-(2-fluoro-6-methylbenzoyl)-6-methyl-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-[(2-hydroxy-2-methylpropyl)amino]phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-(propan-2-ylamino)phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide (CID 158898922) is (2R,3S)-2-[4-(cyclobutylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-2-[4-(cyclopentylamino)phenyl]-N-[4-ethyl-3-(trifluoromethyl)phenyl]-1-(2-fluoro-6-methylbenzoyl)-6-methyl-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-[(2-hydroxy-2-methylpropyl)amino]phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-(propan-2-ylamino)phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide.
What is the SMILES notation for (2R,3S)-2-[4-(cyclobutylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-2-[4-(cyclopentylamino)phenyl]-N-[4-ethyl-3-(trifluoromethyl)phenyl]-1-(2-fluoro-6-methylbenzoyl)-6-methyl-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-[(2-hydroxy-2-methylpropyl)amino]phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-(propan-2-ylamino)phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide?
The canonical SMILES for (2R,3S)-2-[4-(cyclobutylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-2-[4-(cyclopentylamino)phenyl]-N-[4-ethyl-3-(trifluoromethyl)phenyl]-1-(2-fluoro-6-methylbenzoyl)-6-methyl-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-[(2-hydroxy-2-methylpropyl)amino]phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-(propan-2-ylamino)phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide is CCc1ccc(NC(=O)[C@H]2Cc3cc(C)ccc3N(C(=O)c3c(C)cccc3F)[C@H]2c2ccc(NC3CCCC3)cc2)cc1C(F)(F)F.Cc1cc(NC(=O)[C@H]2Cc3ccccc3N(C(=O)c3c(C)cccc3F)[C@H]2c2ccc(NC(C)C)cc2)ccc1CO.Cc1cc(NC(=O)[C@H]2Cc3ccccc3N(C(=O)c3c(C)cccc3F)[C@H]2c2ccc(NC3CCC3)cc2)ccc1CO.Cc1cc(NC(=O)[C@H]2Cc3ccccc3N(C(=O)c3c(C)cccc3F)[C@H]2c2ccc(NCC(C)(C)O)cc2)ccc1CO.
What is the InChIKey of (2R,3S)-2-[4-(cyclobutylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-2-[4-(cyclopentylamino)phenyl]-N-[4-ethyl-3-(trifluoromethyl)phenyl]-1-(2-fluoro-6-methylbenzoyl)-6-methyl-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-[(2-hydroxy-2-methylpropyl)amino]phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-(propan-2-ylamino)phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide?
The InChIKey is JFEJJRDCPVKOFT-ZKDQBUHZSA-N. The full InChI is InChI=1S/C39H39F4N3O2.C36H38FN3O4.C36H36FN3O3.C35H36FN3O3/c1-4-25-13-18-30(22-32(25)39(41,42)43)45-37(47)31-21-27-20-23(2)12-19-34(27)46(38(48)35-24(3)8-7-11-33(35)40)36(31)26-14-16-29(17-15-26)44-28-9-5-6-10-28;1-22-8-7-10-30(37)32(22)35(43)40-31-11-6-5-9-25(31)19-29(34(42)39-28-17-14-26(20-41)23(2)18-28)33(40)24-12-15-27(16-13-24)38-21-36(3,4)44;1-22-7-5-11-31(37)33(22)36(43)40-32-12-4-3-8-25(32)20-30(35(42)39-29-18-15-26(21-41)23(2)19-29)34(40)24-13-16-28(17-14-24)38-27-9-6-10-27;1-21(2)37-27-15-12-24(13-16-27)33-29(34(41)38-28-17-14-26(20-40)23(4)18-28)19-25-9-5-6-11-31(25)39(33)35(42)32-22(3)8-7-10-30(32)36/h7-8,11-20,22,28,31,36,44H,4-6,9-10,21H2,1-3H3,(H,45,47);5-18,29,33,38,41,44H,19-21H2,1-4H3,(H,39,42);3-5,7-8,11-19,27,30,34,38,41H,6,9-10,20-21H2,1-2H3,(H,39,42);5-18,21,29,33,37,40H,19-20H2,1-4H3,(H,38,41)/t31-,36-;29-,33-;30-,34-;29-,33-/m0000/s1.
What are the key properties of (2R,3S)-2-[4-(cyclobutylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-2-[4-(cyclopentylamino)phenyl]-N-[4-ethyl-3-(trifluoromethyl)phenyl]-1-(2-fluoro-6-methylbenzoyl)-6-methyl-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-[(2-hydroxy-2-methylpropyl)amino]phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-(propan-2-ylamino)phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide?
(2R,3S)-2-[4-(cyclobutylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-2-[4-(cyclopentylamino)phenyl]-N-[4-ethyl-3-(trifluoromethyl)phenyl]-1-(2-fluoro-6-methylbenzoyl)-6-methyl-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-[(2-hydroxy-2-methylpropyl)amino]phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-(propan-2-ylamino)phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide has a molecular weight of 2396.86 g/mol, XLogP of 29.95, 29 rotatable bonds, 12 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3S)-2-[4-(cyclobutylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-2-[4-(cyclopentylamino)phenyl]-N-[4-ethyl-3-(trifluoromethyl)phenyl]-1-(2-fluoro-6-methylbenzoyl)-6-methyl-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-[(2-hydroxy-2-methylpropyl)amino]phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide;(2R,3S)-1-(2-fluoro-6-methylbenzoyl)-N-[4-(hydroxymethyl)-3-methylphenyl]-2-[4-(propan-2-ylamino)phenyl]-3,4-dihydro-2H-quinoline-3-carboxamide is sourced from PubChem (CID 158898922), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).